Page last updated: 2024-09-03

bay y3118 and Bacterial Infections, Gram-Positive

bay y3118 has been researched along with Bacterial Infections, Gram-Positive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bongaerts, GP; Hoogkamp-Korstanje, JA	1

Other Studies

1 other study(ies) available for bay y3118 and Bacterial Infections, Gram-Positive

Article	Year
In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections. Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:9 Topics: Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections	1993

Article

Year

In vitro activities of BAY Y3118, ciprofloxacin, ofloxacin, and fleroxacin against gram-positive and gram-negative pathogens from respiratory tract and soft tissue infections.

Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:9

Topics: Anti-Infective Agents; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Microbial Sensitivity Tests; Quinolones; Respiratory Tract Infections

1993